Why the study?
Multiple sclerosis is an immune-mediated demyelinating disease of unclear etiology, with evidence suggesting viral infections might trigger autoimmune mechanisms against myelin.
Does RT-PCR and metagenomics detect a higher prevalence of viral agents in the CSF of patients with multiple sclerosis compared to controls?
Does RT-PCR and metagenomics detect a higher prevalence of viral agents in the CSF of patients with multiple sclerosis compared to controls?
Herpesviridae and Enteroviridae can be detected in the CSF of MS patients, but their prevalence is not significantly higher than in controls, and metagenomics appears less sensitive than real-time PCR for this application.
Does not support routine cerebrospinal fluid viral screening in multiple sclerosis; leaves open whether alternative metagenomic.
Multiple sclerosis (MS) is a chronic, immune-mediated demyelinating disease of the central nervous system of unclear etiology, but there is some evidence that viral infections could be responsible for triggering autoimmune mechanisms against myelin. We searched for viral RNA and DNA in cerebrospinal fluid (CSF) of 34 MS patients and 13 controls using RT-PCR/PCR against common neurotropic viruses. In addition, shotgun DNA- and RNA-based metagenomics were done in 13 MS patients and 4 controls. Specific quantitative real-time RT-PCR/PCR testing revealed the presence of viral nucleic acid in seven (20.59%) MS patients and in one (7.69%) control patient. In MS patients the most frequently detected was human herpesvirus type 6 (HHV-6; 3 cases; 8.82%); followed by Epstein-Barr virus (EBV; 2 cases; 5.88%), varicella zoster virus (VZV; 1 case; 2.94%) and Enterovirus (EV; 1 case; 2.94%). The single identified virus among controls was EBV (7.69%). DNA and RNA metagenomic assays did not identify any known eukaryotic viruses even though three of the analyzed samples were low-level positive by specific quantitative real-time PCR. In conclusion, we detected the presence of Herpesviridae and occasionally Enteroviridae in CSF from patients with MS but their prevalence was not significantly higher than among controls. Metagenomic analysis seems to be less sensitive than real-time RT-PCR/PCR and it did not detect any potential viral pathogens.
No takes yet. Share an insight, caveat, or question.
Perlejewski et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: